Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Breast Cancer Death Rates Declining In Wisconsin, But More Screening Needed, USA
http://www.medicalnewstoday.com/articles/126234.php
State officials mark National Mammography Day by reporting that breast cancer incidence and mortality rates in Wisconsin are declining, but some women are still not getting screened. "The need for effective and early screening is still very important," said Secretary Karen Timberlake.

Governor Rell, A Breast Cancer Survivor, Promotes Awareness Of Early Detection Of Breast Cancer, Connecticut
http://www.medicalnewstoday.com/articles/126228.php
To commemorate National Mammography Day, Governor M. Jodi Rell, a breast cancer survivor, is promoting the importance of breast cancer screening and early detection, especially for women older than 40.

Insomnia In Breast Cancer May Be Predicted By Respiratory Rhythms
http://www.medicalnewstoday.com/articles/126182.php
The breathing and heart rates and cortisol levels of women with metastatic breast cancer can be used to predict if they'll suffer from chronic insomnia and sleep disruptions, a common complaint from patients who want to maintain their quality of life, according to a study by scientists at the University of Rochester Medical Center.

Focus On Women: Advances In Breast Health Presented By Bon Secours St. Francis Health System
http://www.medicalnewstoday.com/articles/126167.php
On Tuesday, October 28, as part of Breast Cancer Awareness Month, physicians and health experts from Bon Secours St. Francis Health System will discuss the importance of detection, treatment, and management of breast disease.

ORLive Presents: Nipple Sparing Mastectomy With Reconstruction Surgery For Breast Cancer; Preserves Entire Nipple-Areola Complex
http://www.medicalnewstoday.com/articles/126151.php
As from Tuesday, October 7, watch surgeons from University Hospitals Case Medical Center perform a nipple sparing mastectomy with complete reconstruction. This breast-preserving procedure provides patients undergoing mastectomy with an excellent cosmetic outcome.

Vanderbilt-Ingram Cancer Center Breast SPORE Renewal Rewards Research
http://www.medicalnewstoday.com/articles/126096.php
Vanderbilt-Ingram Cancer Center's Specialized Programs of Research Excellence (SPORE) in Breast Cancer has received a new round of grant funding from the National Cancer Institute (NCI). The NCI will provide $12 million over the next five years to support and expand Vanderbilt-Ingram's translational research efforts in breast cancer.

----------------------------------------------
** CANCER / ONCOLOGY News **

SNM Hails CMS Decision To Consider Expanding Reimbursement For Cancer
http://www.medicalnewstoday.com/articles/126227.php
In response to a successful data collection effort by the National Oncologic PET Registry (NOPR) showing that positron emission tomography (PET) scans help save the lives of thousands of cancer patients annually, the Centers for Medicare and Medicaid Services (CMS) is weighing an expansion of coverage of PET for all types of cancer.

Editorial In Surgical Neurology Urges Scientists To Clarify Possible Increased Brain Cancer Risk Caused By Use Of Cell Phones
http://www.medicalnewstoday.com/articles/126202.php
Major research initiatives are needed immediately to assess the possibility that using cellular phones may lead to an increased risk of brain tumors, according to an editorial in the November issue of the journal <i>Surgical Neurology</i> (<a href="http://www.

Young Women's Attitudes About Tanning Can Be Altered By Educational Materials And May Reduce Skin Cancer
http://www.medicalnewstoday.com/articles/126196.php
A new study indicates that educational literature can influence young women's use of indoor tanning, not by raising their fear of skin cancer but by changing their attitudes about indoor tanning and promoting healthier alternatives for changing appearance.

Link Between T Cell Response To New Melanoma Antigen And Relapse-Free Survival
http://www.medicalnewstoday.com/articles/126155.php
Melanoma patients infused with a special type of tumor-fighting T cell are more likely to survive without relapse, suggests a new study by researchers in France. Their report was published online on October 20 in the <i>Journal of Experimental Medicine.

Canada Still Exporting Asbestos To Developing Countries
http://www.medicalnewstoday.com/articles/126112.php
Canada continues to export asbestos to developing countries, despite limiting its use in Canada, write Dr. Amir Attaran, David Boyd and Dr. Matthew Stanbrook <a href="http://www.cmaj.ca/press/pg871.

Achilles Heel Of Common Childhood Tumor Identified By Researchers
http://www.medicalnewstoday.com/articles/126102.php
Researchers have discovered a mechanism for the rapid growth seen in infantile hemangioma, the most common childhood tumor.The tumors, which are made up of proliferating blood vessels, affect up to 10 percent of children of European descent, with girls more frequently afflicted than boys.

Nation's Economic Downturn Threatens Continuity Of Care For Chronic Conditions, USA
http://www.medicalnewstoday.com/articles/126098.php
DMAA: The Care Continuum Alliance, responding to reports that many Americans are forgoing basic medical care in the economic downturn, today called for renewed vigilance in the fight against chronic disease and support for care management"While some forms of belt-tightening make sense in tough economic times--dining out less often or carpooling, for example--we can't afford to extend cost-cutting to medical care, especially for people with chronic conditions," DMAA President and CEO Tracey Moorhead says.

A Smear Campaign Against Cervical Cancer, Federation Of Medical Women Of Canada
http://www.medicalnewstoday.com/articles/126094.php
The Federation of Medical Women of Canada (FMWC) is launching a Pap test campaign during Cervical Cancer Awareness week October 27-31, 2008. Women who do not have a family doctor or gynecologist will be able to drop-in or book an appointment with participating doctors during this campaign.

Ann Keen And Mike Richards Lead Fight For The Rights Of Teenage Cancer Patients, UK
http://www.medicalnewstoday.com/articles/126086.php
Ann Keen, MP and Professor Mike Richards CBE will be at the forefront of the debate around the provision of teenage cancer services this weekend when they join 400 teenage cancer patients at Teenage Cancer Trust's conference: "Find Your Sense of Tumour".

Birth Control Has Long Term Effect On Hormone Exposure
http://www.medicalnewstoday.com/articles/126081.php
Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.

FDA Approves Orphan Drug Status For Revolutionary Cancer Drug For Children
http://www.medicalnewstoday.com/articles/126069.php
The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation's unique drug product for children with Ewing's Sarcoma cancer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Requiring HPV Vaccine For U.S. Immigrants Imposes Costs, Inhibits Freedom Of Choice, Opinion Piece Says
http://www.medicalnewstoday.com/articles/126121.php
<BR />Although most women in the U.S. can choose whether to take Merck's human papillomavirus vaccine Gardasil, immigrant families with young daughters must "either abide by the mandate" <A href="http://www.

A Smear Campaign Against Cervical Cancer, Federation Of Medical Women Of Canada
http://www.medicalnewstoday.com/articles/126094.php
The Federation of Medical Women of Canada (FMWC) is launching a Pap test campaign during Cervical Cancer Awareness week October 27-31, 2008. Women who do not have a family doctor or gynecologist will be able to drop-in or book an appointment with participating doctors during this campaign.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

Tomophase To Exhibit First In-Vivo Cross-Sectional Images Of Pulmonary Stenting Using Proprietary OCT System
http://www.medicalnewstoday.com/articles/126250.php
Tomophase Corporation announced today that it will display the first in-vivo cross-sectional images of implanted pulmonary stents using their proprietary optical coherence tomography (OCT) system at the CHEST meeting in Philadelphia, Oct.

Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage Of Bavituximab Phase II Lung Cancer Trial
http://www.medicalnewstoday.com/articles/126066.php
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for cancer and serious viral infections, today announced that it has completed enrollment in the first stage of its Phase II trial evaluating a combination regimen of bavituximab with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Geron Initiates Clinical Trial Of GRN163L In Combination With Bortezomib And Dexamethasone In Patients With Multiple Myeloma
http://www.medicalnewstoday.com/articles/126213.php
Geron Corporation (Nasdaq:GERN) today announced that it has enrolled the first multiple myeloma patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in combination with other treatments.

Non-Hodgkin Lymphoma Patients' Survival Affected By Socioeconomic And Treatment Factors
http://www.medicalnewstoday.com/articles/126178.php
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of <i>CANCER</i>, a peer-reviewed journal of the American Cancer Society.

Making A Good Anti-Leukemia Drug Even Better
http://www.medicalnewstoday.com/articles/126157.php
A recently identified cancer-causing protein makes the anti-leukemia drug imatinib, less effective. By blocking the protein, an international team of researchers was able to slow the spread of leukemia cells in culture.

3.6% Annual Growth In The Non-Hodgkin's Lymphoma Drug Market Will Be Driven By The Continued Dominance Of Rituxan/MabThera
http://www.medicalnewstoday.com/articles/126141.php
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2017, robust 3.6 percent annual growth in the non-Hodgkin's lymphoma drug market will be driven by increasing market penetration of Biogen Idec/Genentech/Chugai/Zenyaku Kogyo's Rituxan/Roche's MabThera, particularly in the chronic lymphocytic leukemia market.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Ariad Announces Start Of Phase 2 Clinical Study Of Oral Deforolimus In Patients With Prostate Cancer
http://www.medicalnewstoday.com/articles/126212.php
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced the initiation of a Phase 2 clinical trial by Merck & Co., Inc. to evaluate the safety and efficacy of oral deforolimus, ARIAD's investigational mTOR inhibitor, in patients with advanced prostate cancer.

Interim Phase II Results Support Efficacy Of CB7630 (Abiraterone Acetate) In Advanced Prostate Cancer Patients
http://www.medicalnewstoday.com/articles/126061.php
Cougar Biotechnology, Inc. (NASDAQ:CGRB) today announced that results from an ongoing Phase II clinical trial of Cougar's investigational drug CB7630 (abiraterone acetate) were presented today at the Prostate Cancer Foundation Scientific Retreat.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .